Author

Ryan N. Robb

University of North Carolina at Chapel HillORCID 0000-0001-7661-7902Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Clint A. StalneckeriD· 2 shared Kirsten L. BryantiD· 2 shared Addison G. StameyiD· 1 shared Adrienne D. CoxiD· 1 shared Alec J. VaughaniD· 1 shared Andrew J. AguirreiD· 1 shared Andrew M. WatersiD· 1 shared Antje SchaeferiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Clint A. StalneckerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 29, 2026

Vertical inhibition of the autophagy pathway impairs growth and enhances sensitivity to mTORC1 inhibition in pancreatic ductal adenocarcinoma

Mallory K. Roach, Seamus E. Degan, Jonathan M. DeLiberty…·Kirsten L. Bryant

This study identifies that vertical inhibition of the autophagy pathway enhances sensitivity to mTORC1 inhibition in PDAC, improving therapeutic efficacy.

DOI 10.64898/2026.06.28.734981

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 21, 2026

Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer

Wen-Hsuan Chang, Alec J. Vaughan, Addison G. Stamey…·Channing J. Der

This study identifies KEAP1 loss as a resistance mechanism to KRAS inhibitors in pancreatic and lung cancer and shows that combining glutamine inhibition with KRAS inhibitors can overcome this resistance.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky